ICICI Lombard Schedules Board Meeting on April 15, 2026 for Q4FY26 Results and Final Dividend Recommendation
ICICI Lombard General Insurance Company Limited announced a board meeting on April 15, 2026, in Mumbai to consider and approve audited financial results for Q4FY26 and FY2026, along with final dividend recommendation. The company has implemented a trading window closure from April 1-17, 2026, for all designated persons and their immediate relatives in compliance with SEBI regulations. The formal communication was filed with BSE and NSE on March 25, 2026, by Company Secretary Vikas Mehra.

*this image is generated using AI for illustrative purposes only.
ICICI Lombard General Insurance Company Limited has announced that its Board of Directors will convene on April 15, 2026, to review and approve crucial financial matters for the concluded financial year. The meeting, scheduled to take place in Mumbai, will focus on the company's audited financial results and potential dividend distribution for shareholders.
Board Meeting Agenda
The board meeting has been convened to address two primary objectives for the financial year ending March 31, 2026:
| Agenda Item: | Details |
|---|---|
| Financial Results: | Consider and approve Audited Financial Results & Audited Financial Statements for Q4FY26 and FY2026 |
| Dividend Recommendation: | Recommend final dividend, if any, for FY2026 |
| Meeting Date: | April 15, 2026 |
| Meeting Location: | Mumbai |
Regulatory Compliance and Trading Window Closure
In adherence to the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has issued this intimation under Regulation 29. The announcement ensures transparency and provides adequate notice to stakeholders regarding the upcoming financial disclosures.
To comply with insider trading regulations, ICICI Lombard General Insurance has implemented a trading window closure affecting all designated persons and their immediate relatives. This measure aligns with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and the company's internal Code of Conduct.
| Trading Window Details: | Information |
|---|---|
| Closure Period: | April 1, 2026 to April 17, 2026 (both days inclusive) |
| Affected Parties: | All Designated Persons and their immediate relatives |
| Purpose: | Declaration of Q4FY26 results and dividend recommendation |
| Regulatory Basis: | SEBI Insider Trading Regulations and Company Code of Conduct |
Corporate Communication
The formal communication was signed by Vikas Mehra, Company Secretary, on March 25, 2026, and has been submitted to both major stock exchanges where the company's shares are listed. The official intimation was addressed to the Listing Departments of BSE Limited and National Stock Exchange of India Limited, demonstrating the company's commitment to maintaining transparent communication with regulatory authorities.
| Exchange Communication: | Details |
|---|---|
| BSE Scrip Code: | 540716 |
| NSE Symbol: | ICICIGI |
| Filing Date: | March 25, 2026 |
| Authorized Signatory: | Vikas Mehra, Company Secretary |
The upcoming board meeting represents a significant milestone in the company's annual financial reporting cycle, as it will provide comprehensive insights into the company's performance for the quarter and full financial year ending March 31, 2026. Stakeholders and investors will closely monitor the outcomes, particularly regarding the potential final dividend recommendation for FY2026.
Historical Stock Returns for ICICI Lombard General Insurance
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.32% | -4.60% | -9.92% | -7.16% | -1.83% | +25.84% |
How might ICICI Lombard's Q4FY26 results impact the broader general insurance sector's valuation and investor sentiment?
What factors could influence the board's decision on dividend distribution, and how might it compare to previous years' payouts?
Will the company's financial performance for FY2026 affect its competitive positioning against other major insurance players in India?


































